Experienced in Hemangioblastoma

Dr. Kevin D. Judy

Neurosurgery
Jefferson University Physicians
834 Chestnut St, Terrace Suite T 150, 
Philadelphia, PA 
Offers Telehealth
Experienced in Hemangioblastoma
Jefferson University Physicians
834 Chestnut St, Terrace Suite T 150, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kevin Judy is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. Judy is rated as an Experienced provider by MediFind in the treatment of Hemangioblastoma. His top areas of expertise are Glioma, Meningioma, Glioblastoma, Awake Craniotomy, and Gamma Knife Radiosurgery.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hemangioblastoma.

Specialties
Neurosurgery
Licenses
Neurological Surgery in PA
Hospital Affiliations
Thomas Jefferson University Hospital
Beebe Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

JEFFERSON UNIVERSITY PHYSICIANS
834 Chestnut St, Terrace Suite T 150, Philadelphia, PA 19107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Analysis of Cell Count, Viability, and Immunogenicity of Deidentified Discarded Newly Diagnosed Glioblastoma Tissue and More Broadly Other Newly Diagnosed Solid Tumor Tissues From the Operating Room
Analysis of Cell Count, Viability, and Immunogenicity of Deidentified Discarded Newly Diagnosed Glioblastoma Tissue and More Broadly Other Newly Diagnosed Solid Tumor Tissues From the Operating Room
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Procedure
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Combination product, Procedure, Drug
Study Drugs: IGV-001 Cell Immunotherapy, Temozolomide
Study Phase: Phase 2
Phase I Study in Humans Evaluating the Safety of Rectus Sheath Implantation of Diffusion Chambers Encapsulating Autologous Malignant Glioma Cells Treated With Insulin-like Growth Factor Receptor-1 Antisense Oligodeoxynucleotide (IGF-1R/AS ODN) in 32 Patients With Newly Diagnosed Malignant Glioma
Phase I Study in Humans Evaluating the Safety of Rectus Sheath Implantation of Diffusion Chambers Encapsulating Autologous Malignant Glioma Cells Treated With Insulin-like Growth Factor Receptor-1 Antisense Oligodeoxynucleotide (IGF-1R/AS ODN) in 32 Patients With Newly Diagnosed Malignant Glioma
Enrollment Status: Completed
Publish Date: May 07, 2025
Intervention Type: Drug
Study Phase: Phase 1
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug, Radiation, Procedure
Study Phase: Phase 1
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Enrollment Status: Completed
Publish Date: April 24, 2025
Intervention Type: Device
View 4 Less Clinical Trials

43 Total Publications

Recurrent intracranial myoepithelioma: clinical course and long-term follow-up. Illustrative case.
Recurrent intracranial myoepithelioma: clinical course and long-term follow-up. Illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: February 26, 2025
Similar Doctors
Advanced in Hemangioblastoma
Dr. Seth Joseffer
Neurosurgery
Advanced in Hemangioblastoma
Dr. Seth Joseffer
Neurosurgery

Princeton Brain, Spine And Sports Medicine - Princeton

731 Alexander Road, Suite 200, 
Princeton, NJ 
 (38.0 miles away)
609-921-9001
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Seth Joseffer is a Neurosurgery provider in Princeton, New Jersey. Dr. Joseffer is rated as a Distinguished provider by MediFind in the treatment of Hemangioblastoma. His top areas of expertise are Hydrocephalus, Spinal Stenosis, Subdural Hematoma, Microdiscectomy, and Cervical Disc Surgery. Dr. Joseffer is currently accepting new patients.

Pawan Rastogi
Advanced in Hemangioblastoma
Dr. Pawan Rastogi
Neurosurgery
Advanced in Hemangioblastoma
Dr. Pawan Rastogi
Neurosurgery

Delaware Neurosurgical Group

774 Christiana Road, Suite 202, 
Newark, DE 
 (34.0 miles away)
302-366-7671
Experience:
37+ years
Languages Spoken:
English
See accepted insurances

Pawan Rastogi is a Neurosurgery provider in Newark, Delaware. Dr. Rastogi has been practicing medicine for over 37 years and is rated as a Distinguished provider by MediFind in the treatment of Hemangioblastoma. His top areas of expertise are Chronic Subdural Hematoma, Spondylolisthesis, Radiation Induced Meningioma, Microdiscectomy, and Herniated Disc Surgery.

Advanced in Hemangioblastoma
Dr. Steven J. Barrer
Neurosurgery
Advanced in Hemangioblastoma
Dr. Steven J. Barrer
Neurosurgery
2510 Maryland Rd, Ste 185, 
Willow Grove, PA 
 (14.7 miles away)
215-657-5886
Languages Spoken:
English
See accepted insurances

Steven Barrer is a Neurosurgery provider in Willow Grove, Pennsylvania. Dr. Barrer is rated as an Advanced provider by MediFind in the treatment of Hemangioblastoma. His top areas of expertise are Apoplexy, Delirium, Hydrocephalus, Gastrostomy, and Awake Craniotomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Judy's expertise for a condition
ConditionClose
View All 15 Distinguished Conditions
View All 8 Advanced Conditions
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile